Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03473782 · ClinicalTrials.gov registry record
Overactive Bladder (OAB) Voiding Diary and Urodynamics Correlation Study
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 123
- Enrollment target
NCT03473782: Completed study, sponsored by NYU Langone Health.
NCT03473782 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 123 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03473782 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 123 participants
- Enrollment target
Study Summary
This is a prospective cohort study study with the primary aim of identifying the strongest correlating parameters between voiding diaries and UDS studies most predictive for each type of urologic condition. Investigators will focus on OAB related conditions, as these are symptoms
Primary Outcome
patients will record urgency in diary
Interventions
- OTHER Voiding Diary
- OTHER Urodynamics Correlation Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2015-10-12 |
| Est. Completion | 2023-08-08 |
What the finished NCT03473782 record still lists
NCT03473782 is an observational study that tracks outcomes without assigning an intervention. The registered 123 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Voiding Diary is the first listed.
NCT03473782 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03473782 about?
NCT03473782 is a clinical study titled "Overactive Bladder (OAB) Voiding Diary and Urodynamics Correlation Study". This is a prospective cohort study study with the primary aim of identifying the strongest correlating parameters between voiding diaries and UDS studies most predictive for each type of urologic condition. Investigators will focus on OAB related conditions, as these are symptoms
What is the current status of trial NCT03473782?
This trial is currently completed. The enrollment target is 123 participants. The study started on 2015-10-12. Estimated completion is 2023-08-08.
What interventions are being tested in trial NCT03473782?
The interventions under investigation include: Voiding Diary (OTHER), Urodynamics Correlation Study (OTHER).
Who is sponsoring clinical trial NCT03473782?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05285891 · 123 participants · Phase 4
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
- NCT05334368 · 123 participants · Phase 3
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
- NCT06088355 · 123 participants · NA
Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease
- NCT06111131 · 123 participants · NA
Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI